Monday, Aug 03, 2020 | Last Update : 06:28 PM IST

132nd Day Of Lockdown

Maharashtra44122827680915576 Tamil Nadu2576131964834132 Andhra Pradesh158764828861474 Delhi1376771233174004 Karnataka134819577252496 Uttar Pradesh92921533571730 West Bengal75516527301678 Telangana6766048609551 Gujarat63675466892482 Bihar5727036637322 Rajasthan4441031216706 Assam4290532385105 Haryana3651929690433 Odisha3491321955236 Madhya Pradesh3353523550886 Kerala259121446383 Jammu and Kashmir2141613127396 Punjab1785311466423 Jharkhand121884513115 Chhatisgarh9608699158 Uttarakhand7593443786 Goa6530466853 Tripura5248346323 Puducherry3806230952 Manipur283117377 Himachal Pradesh2654150813 Arunachal Pradesh19359693 Nagaland19356484 Chandigarh111769819 Meghalaya8742645 Sikkim6582891 Mizoram4702580
  Business   Companies  21 Jul 2020  Novartis profits rise despite coronavirus sales swings

Novartis profits rise despite coronavirus sales swings

PTI
Published : Jul 21, 2020, 1:22 pm IST
Updated : Jul 21, 2020, 1:22 pm IST

Sales were mostly affected by lower new patient starts and significant reduction in patient visits to physicians, said Novartis

  Novartis reported Tuesday higher profits in the first half of the year despite the coronavirus pandemic causing swings in sales. (AFP Photo)
  Novartis reported Tuesday higher profits in the first half of the year despite the coronavirus pandemic causing swings in sales. (AFP Photo)

ZURICH: Swiss pharma giant Novartis reported Tuesday higher profits in the first half of the year despite the coronavirus pandemic causing swings in sales.

During the first six months of the year net profit came in at $4 billion (3.5 billion euros), a 9 percent increase when currency fluctuations are stripped out.

 

Sales rose by 6 percent from the same period last year to $23.6 billion.

But the half-year figures obscure considerable swings in sales and profits due to the novel coronavirus pandemic.

If sales rose by 11 percent in the first quarter as clients stocked up on medicines when the virus began to spread around the world, sales dipped by 1 percent in the second quarter.

"During the second quarter, COVID-19 had an impact on our business with forward purchasing from the first quarter largely reversing," the company said in a statement.

Lockdowns and the focus of medical systems on treating coronavirus and urgent patients also had an impact on the sales of certain treatments.

 

"Sales were mostly affected by lower new patient starts and significant reduction in patient visits to physicians," said Novartis.

There was also a similar evolution in quarterly earnings, with a 16 percent gain in net profit during the first three months turning into a 4 percent drop in the second quarter.

Novartis said it expects mid single digit sales growth for the year, with a low double digit gain in its measure of core operating income. Over the first half of the year, core operating income rose by 19 percent.

Tags: novartis, coronavirus pandemic, novartis sales, covid-19 lockdown, coronavirus crisis
Location: Switzerland, Zürich, Zürich